A review of recent research into myelodysplastic syndromes (MDS) shows a range of potential therapeutic targets. New research into the pathogenesis of myelodysplastic syndromes (MDS) may help aid the ...

Nearly 25 years after arriving at Fred Hutch Cancer Center for his hematology-oncology fellowship, Bart Scott, MD, has been named the Miklos Kohary and Natalia Zimonyi Kohary Endowed Chair, ...

Myelodysplastic syndrome is an extremely heterogeneous disease, and there is no definitive cure, so these investigators wanted a better understanding of patients’ priorities regarding their care, ...

Hypomethylating agents are standard in MDS treatment, with new drugs like Rytelo enhancing anemia management. Targeted therapies for IDH1/IDH2 mutations offer promising options, though challenges in ...

Smokers with myelodysplastic syndromes (MDS) or a precursor condition had elevated levels of genetic mutations linked to the disease, a new study shows. The study also found that heavier smokers ...

Myelodysplastic syndromes (MDS) are treated based on type and risk assessment, but traditional therapies may not work for everyone. Clinical trials offer a way to explore emerging treatments and ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. “It looks like, in the low-risk [myelodysplastic ...

Editor’s note: This is an automatically generated transcript. Please notify editor@healio.com if there are concerns regarding accuracy of the transcription. In terms of future MDS research, a lot of ...

Nutrition may improve quality of life and outcomes in people with myelodysplastic syndromes (MDS). Myelodysplastic syndromes (MDS) are a type of blood cancer. Typically, blood stem cells mature into ...